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Abstract
Background For the diagnosis of prosthetic joint infection, real evidence-based guidelines to aid clinicians in choosing the most
accurate diagnostic strategy are lacking.
Aim and Methods To address this need, we performed a multidisciplinary systematic review of relevant nuclear medicine,
radiological, orthopaedic, infectious, andmicrobiological literature to define the diagnostic accuracy of each diagnostic technique
and to address and provide evidence-based answers on uniform statements for each topic that was found to be important to
develop a commonly agreed upon diagnostic flowchart.
Results and Conclusion The approach used to prepare this set of multidisciplinary guidelines was to define statements of interest
and follow the procedure indicated by the Oxford Centre for Evidence-based Medicine (OCEBM).
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Preamble
The European Association of Nuclear Medicine (EANM) is a
professional nonprofit medical association that facilitates
communication worldwide between individuals pursuing clin-
ical and research excellence in nuclear medicine. The EANM
was founded in 1985. EANM members are physicians, tech-
nologists, and scientists specializing in the research and prac-
tice of nuclear medicine.
The EANM will periodically define new guidelines for
nuclear medicine practice to help advance the science of nu-
clear medicine and to improve the quality of service to patients
throughout the world. Existing practice guidelines will be
reviewed for revision or renewal, as appropriate, on their fifth
anniversary or sooner, if indicated.
Each practice guideline, representing a policy statement by
the EANM, has undergone a thorough consensus process in
which it has been subjected to extensive review. The EANM
recognizes that the safe and effective use of diagnostic nuclear
medicine imaging requires specific training, skills, and tech-
niques, as described in each document. Reproduction or mod-
ification of the published practice guideline by those entities
not providing these services is not authorized.
These guidelines are an educational tool designed to assist
practitioners in providing appropriate care for patients. They
are not inflexible rules or requirements of practice and are not
intended, nor should they be used, to establish a legal standard
of care. For these reasons and those set forth below, the ESR,
EBJIS, ESCMID, and the EANM suggest caution against the
use of these guidelines in litigation in which the clinical deci-
sions of a practitioner are called into question.
The ultimate judgment regarding the propriety of any spe-
cific procedure or course of action must be made by the phy-
sician or medical physicist in light of all the circumstances
presented. Thus, there is no implication that an approach dif-
fering from the guidelines, standing alone, is below the stan-
dard of care. To the contrary, a conscientious practitioner may
responsibly adopt a course of action different from that set
forth in the guidelines when, in the reasonable judgment of
the practitioner, such course of action is indicated by the con-
dition of the patient, limitations of available resources, or ad-
vances in knowledge or technology subsequent to publication
of the guidelines.
The practice of medicine includes both the art and the sci-
ence of the prevention, diagnosis, alleviation, and treatment of
disease. The variety and complexity of human conditions
makes it impossible to always reach the most appropriate di-
agnosis or to predict with certainty a particular response to
treatment. Therefore, it should be recognized that adherence
to these guidelines will not ensure an accurate diagnosis or a
successful outcome. All that should be expected is that the
practitioner will follow a reasonable course of action based
on current knowledge, available resources, and the needs of
the patient, to deliver effective and safe medical care. The sole
purpose of these guidelines is to assist practitioners in achiev-
ing this objective.
Introduction
Because of increased life expectancy, the number of joint
prosthesis replacements continues to grow at a significant rate,
with several millions prosthetic joints implanted each year
worldwide [1]. Most of the time this surgery results in better
joint function and pain relief, and the procedure itself is safe
and cost-effective [2]. However, prosthetic joint infection
(PJI) is a complication that can occur, with an incidence rang-
ing from 2.0% to 2.4% for primary interventions [3], but in-
creasing to as high as 20% for revision procedures [4], leading
to a true economic burden, since costs are very high when an
infection develops [3]. PJI is a serious condition that may lead
to repeated surgical interventions, prolonged hospitalization,
high costs, and significant morbidity, although low mortality.
PJIs are usually classified in relation to the time of onset
after surgery: (i) early, within the first 3 months after surgery,
(ii) delayed (between 3 months and 2 years after surgery), and
(iii) late (more than 2 years after surgery) [5]. Microorganisms
may reach the prosthesis at the time of implantation or later by
haematogenous spread [6, 7].
Early infection is often easy to recognize by acute pain in
the wound area, redness, swelling, wound leakage, heat, and
fever. Late infection is often caused by haematogenous spread,
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with symptoms from both the affected joint and the primary
infection site. The main diagnostic problem is the delayed,
often low-grade infection with mostly nonspecific symptoms.
In all PJIs, a delay in starting an appropriate antibiotic regimen
and surgical treatment has an important impact on the chance
of saving the prosthesis and joint function. Therefore, early
diagnosis is of utmost importance.
There is no single routine test available that can diagnose
PJI with sufficient accuracy. Cultures, biopsies, serum inflam-
matory markers, and imaging techniques all have their pros
and cons. C-reactive protein (CRP), erythrocyte sedimentation
rate (ESR), and leukocyte count are not sensitive or specific
enough to detect or exclude a PJI. Joint aspiration itself in-
volves a risk of infection, and its sensitivity is highly variable.
In general, a combination of clinical, laboratory, microbiolog-
ical, and imaging tests are performed based on personal expe-
rience, techniques available in the institute, and cost aspects.
Indeed, most signs and symptoms that might indicate the pres-
ence of a PJI may be simply related to an aseptic loosening of
the prosthesis or to a soft tissue infection. Since loosening, soft
tissue infection without osteomyelitis, and PJI require differ-
ent treatment strategies (NSAIDs, antibiotic therapy, or sur-
gery for explant and re-implant), the correct differential diag-
nosis among these clinical situations is crucial.
The development of biofilms plays a strategic role in the
pathogenesis of PJI. Microorganisms adhere to the implant
and form a biofilm, within which they are protected from the
host immune system and most antibiotics [7, 8]. The most
frequent etiologic agents are staphylococci, accounting for
more than 50% of PJIs [8]. Staphylococcus aureus is most
commonly isolated in early infection, whereas coagulase-
negative staphylococci are more frequent in late infection [8].
Other commonly isolated organisms in late infections are
streptococci (9–10%), enterococci (3–7%), and anaerobes (2–
4%) [7]. Gram-negative bacteria, mostly Pseudomonas
aeruginosa, Enterobacter spp., and Proteus spp., even if rel-
atively uncommon agents, have an important clinical impact
because of the difficulty in treating them [9, 10]. Overall,
about 20% of PJIs are polymicrobial and 7–11% are culture-
negative [11, 12]. Unusual pathogens such as Candida spp.,
Brucella spp., and mycobacteria have also been reported [13].
Other commonly isolated organisms in late infections are
streptococci (9–10%), enterococci (3–7%), and anaerobes (2–
4%) [7]. Gram-negative bacteria, mostly Pseudomonas
aeruginosa, Enterobacter spp., and Proteus spp., even if rel-
atively uncommon agents, have an important clinical impact
because of the difficulty in treating them [9, 10]. Overall,
about 20% of PJIs are polymicrobial and 7–11% are culture-
negative [11, 12]. Unusual pathogens such as Candida spp.,
Brucella spp., and mycobacteria have also been reported [13].
There are several papers available with recommenda-
tions for diagnosing PJI, all with limitations: not focusing
strictly on PJI, not focused on a diagnostic flow chart, not
including nuclear medicine, based only on expert opinion
and/or local consensus meetings, or not up to date (not
analysing the currently available diagnostic techniques).
Therefore, multidisciplinary evidence-based guidelines
are needed, including the most relevant imaging tech-
niques to support the most accurate diagnostic strategy.
To achieve this goal, nuclear medicine physicians orga-
nized a pre-congress meeting with infectious disease spe-
cialists, radiologists, and orthopaedic surgeons on the oc-
casion of the 20th congress of the European Association
of Nuclear Medicine (EANM), where each professional
discipline explained their points of view, and together
they drafted a possible diagnostic flowchart for PJI [14].
As this was still only expert opinion, the aim now be-
comes to define a real evidence-based diagnostic flow-
chart for PJI by performing a thorough systematic review
of the relevant literature in the areas of nuclear medicine,
radiology, infectious diseases, and microbiology to define
the diagnostic accuracy of each technique and to address
and provide evidence-based answers on uniform state-
ments for each topic found to be important for developing
a diagnostic flowchart.
Methods
Working group
After several joint symposia and reading of several available
guidelines based only on expert opinion, we recognised that a
multidisciplinary evidence-based guideline for diagnosing pe-
ripheral bone infections was needed. This joint society project
started in 2015, and a working group was created with dele-
gates from four European societies: the European Association
of Nuclear Medicine (EANM), the European Society of
Radiology (ESR), the European Bone and Joint Infection
Society (EBJIS), and the European Society of Clinical
Microbiology and Infectious Diseases (ESCMID). The dele-
gates first met in Vienna (November 2015) to define the state-
ments and after that in Rome (February 2016) to jointly define
the revised and final statements, based on the literature evi-
dence that had first been circulated among all participants.
Finally, all delegates approved the final version of each
statement.
Statements
Uniform statements were addressed for each topic, with the
aim of positioning all diagnostic procedures in a commonly
agreed upon and evidence-based diagnostic flowchart. Each
consensus statement is followed by comments derived from
analysis of the relevant literature.
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Literature search
An extensive literature search of the PubMed/Medline and
Scopus databases was conducted (for the period from 1
January 2000 up to December 2015) for each statement and
for overall diagnostic accuracy of each diagnostic technique.
Search terms were defined in agreement with all delegates
from the four participating societies. Inclusion of the papers
per statement was based on a PICO (Population/problem –
Intervention/indicator – Comparator – Outcome) question to
search for evidence after converting the PICO question into a
search strategy. This strategy is described in detail by the
Oxford Centre for Evidence-based Medicine (OCEBM)
[15]. Case reports, reviews, and papers with fewer than 10
patients were excluded, as well as non-English-language pa-
pers. Systematic reviews were included. A cross-search with
references included in the retrieved articles was also per-
formed to look for further evidence. Based on expert experi-
ence, if some known paper was not retrieved by the search, it
was added for competence.
Method for scoring the papers
All included papers per statement were thoroughly read and
analysed, and a Blevel of evidence^ was provided in consen-
sus with all delegates for each paper according to the docu-
ments for levels of evidence provided by the OCEBM [16].
Finally, putting all levels of evidence for all included papers
together, a final level of evidence was provided, again in
agreement among all delegates, for each statement.
Current diagnostic approach for PJI
The diagnostic approach in patients with suspected PJI is ex-
tremely variable from centre to centre, depending on local
experience, technological equipment, and adherence to avail-
able guidelines.
However, thus far there are no published Bevidence-based^
guidelines to guide the diagnostic flow of PJI. Clinical exam-
ination and laboratory tests, together with a planar x-ray film,
are the first steps. These are followed by biopsies, or joint
aspiration with microbiological analysis or advanced imaging
modalities such as radiological and nuclear medicine exami-
nations. These are explained in more detail in Appendix 1
[17–47], and a statement on the concerns regarding the use
of ionizing radiation is described in Appendix 2.
Consensus statements
All PICOs performed for the statements and the list of publi-
cations selected for the level of evidence are mentioned in
Appendix 3.
1. PJI should be suspected when one or more of the
following symptoms and signs are present: otherwise un-
explained pain and/or fever, redness, swelling, scar inflam-
mation, and movement limitations. These symptoms are
(especially in the chronic phase) not specific and require
other investigations.
Level of evidence: 4.
The main clinical signs of early PJI are persistent local
pain, erythema, swelling, wound healing disturbance (leak-
age), and fever. In delayed and chronic infection occurring
many years after prosthesis insertion, clinical signs may be
absent; when present, they are represented by persistent or
increasing joint pain and a loose prosthesis.
Symptoms are not specific for infection, and it is not easy to
distinguish PJI from aseptic loosening by clinical history and
physical examination alone. As a consequence, patients with
one or more of the above-mentioned signs and symptoms
should undergo further investigation for diagnosing or exclud-
ing the presence of infection [48–54].
2. Sinus tract and purulent discharge are clear signs of
prosthetic joint infection.
Level of evidence: 5.
There are no papers published on this specific issue; rather,
this is a general belief based on the logical assumption that,
given the natural colonization of the skin, these bacteria will
certainly colonize the exposed implant. However, no literature
was found providing evidence that a sinus tract with purulent
discharge is a sign of PJI. There is no evidence that microbi-
ological analysis of tissue or fluid from sinus tracts is reliable
for diagnosis.
3. CRP and ESR should always be performed in pa-
tients with suspected prosthetic joint infection. A normal
value does not rule out PJI.
Level of evidence: 2.
Patients presenting with clinical signs of prosthetic joint
infection (i.e. fever, unexplained pain at the site of
arthroplasty, prosthetic loosening, or a sinus tract) should be
subjected to screening for inflammatory markers in serum. C-
reactive protein (CRP) and erythrocyte sedimentation rate
(ESR) are good preliminary tests. Screening of these markers
can be performed rapidly, inexpensively, and with minimal
inconvenience. Although there is considerable variation in
sensitivity (SE) and specificity (SP) for both CRP (SE 21–
100%, SP 20–96%) and ESR (SE 58–97%, SP 33–90.9%),
in general they show good diagnostic value, and are of rele-
vance particularly for therapy follow-up. A threshold of
10 mg/l for CRP and 30 mm/h for ESR of is recommended
for diagnostic purposes. One level 1 study and 32 level 2
studies addressed the diagnostic efficacy of CRP and ESR in
serum [19, 55–82]. However, when testing for CRP and ESR,
one should keep in mind that both markers can be influenced
by numerous factors (i.e. neoplastic and inflammatory condi-
tions, age, and technical details). Furthermore, CRP is
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produced in the liver, and especially in low-grade chronic PJI,
levels may not be elevated. Therefore, a careful history and
physical examination are mandatory. Several studies suggest
using the combination of ESR and CRP [56, 59, 83]. In any
case, if one of these markers is above the threshold, further
diagnostic tests should be performed. Low CRP and ESR do
not rule out PJI.
4. In the case of fever, blood cultures should always be
performed in patients suspected of having prosthetic joint
infection in order to identify the causative bacteria.
Level of evidence: 5.
Microorganisms may reach the prosthesis at the time of
implantation or later by haematogenous spread [6, 7].
Haematogenous seeding can occur at any time after joint
implantation. The main sources of bacteraemia are skin, respi-
ratory tract, dental procedures, and urinary tract infection [7].
Haematogenous spread of S. aureus can also occur in pa-
tients without a detectable primary focus [84].
No studies specifically assessed the role of blood cultures
in diagnosing PJI. However, in consideration of the frequent
haematogenous origin of PJI, it is recommended that blood
cultures be performed in patients with suspected PJI who have
fever.
5. Conventional radiography is the first imagingmodal-
ity to perform in patients with suspicion of PJI for diag-
nosis and follow-up.
Level of evidence: 2.
Conventional radiography is regularly used to evaluate
joint prostheses after implantation and follow-up, as these
procedures are able to detect any potential abnormality involv-
ing both the implant and the surrounding bone. For this rea-
son, conventional radiography should always be performed.
Regarding PJI, conventional radiography often yields normal
results or may detect nonspecific signs of soft tissue swelling.
Serial plain radiography has been reported to have sensitivity
of 14% and specificity of 70% in detecting implant-associated
infections. Radiographic signs that may reveal PJI with high
specificity are gas formation and active, immature periostitis.
Radiographic signs with low specificity include soft tissue
swelling, periprosthetic lucency, and component loosening.
However, differentiation between septic and aseptic
periprosthetic lucency and component loosening is almost im-
possible on conventional radiography. Also, these signs are
visible only when almost 30% of the bone mass has been lost;
thus, 50% of radiographs remain normal despite the presence
of infection [85–87].
6. Ultrasound can detect complications around the
prosthesis, but the capacity for detecting infection is
controversial.
Level of evidence: 2.
Van Holsbeeck et al. reported 100% sensitivity and 74%
specificity for infection when the a capsule-to-bone distance
was >4 mm, while 100% specificity was observed when the
capsule-to-bone distancewas >3.2mm and extracapsular fluid
was found in the hip [88]. These findings were questioned by
Weybright et al. [89], who reported that anterior distension of
the hip capsule was not predictive of infection.
7. Imaging may be useful for guiding joint aspiration or
periprosthetic tissue biopsy.
Level of evidence: 2.
One of the challenges of correct aspiration or biopsy in and
around the implant is placing the needle exactly in the area of
interest. Open aspiration and biopsy can be done in a surgical
theatre, but this approach is highly invasive. Fluoroscopy can
be used as a guide, but it does not correctly show soft tissues
and fluids, and it uses ionizing radiation. US can be used to
guide the needle in the joint space and in the soft tissue around
the implant without the use of ionizing radiation. Eisler et al.
reported 7% sensitivity and 66% specificity for ultrasound-
guided capsular biopsy, while fluid aspiration was always
falsely sterile [90]. Battaglia et al. demonstrated 69% sensitiv-
ity, 94% specificity, and 83% accuracy for ultrasound-guided
periprosthetic joint aspiration [91]. CT-guided aspiration has
been reported to have 70% sensitivity, 100% specificity, and
84% accuracy for diagnosis of infection [92].
8. Leukocyte count and differential in synovial fluid has
high diagnostic accuracy in detecting PJI.
Level of evidence: 2.
Patients with abnormal CRP and/or ESR should undergo
aspiration of the hip or knee. We recommend that aspiration
fluid be tested for white blood cell count (WBC) and percent-
age of neutrophils. Our systematic review of the literature
showed high sensitivity and specificity for both tests.
Synovial white blood cell count had sensitivity of 36–100%
and specificity of 80–99%. Differential count had sensitivity
of 84–100% and specificity of 80–99%. A threshold for white
blood cell count of >3000 cells/μl seems justified based on the
studies found (the thresholds from various reports vary from
1700 cells/μl to 5000 cells/μl). Neutrophil percentage > 70%
is highly suggestive of prosthetic joint infection (range 65–
80%). Fourteen level 2 studies addressed the diagnostic effi-
cacy of synovial fluid white blood cell count and differential
[19, 21, 52, 58, 60–63, 71, 76, 77, 80, 93, 94]. Aspiration of
synovial fluid for white blood cell count has advantages. It can
be performed in the outpatient setting, and the results do not
appear to be influenced by antimicrobial treatment [94].
9. Bacterial culture from joint aspiration has high diag-
nostic accuracy in detecting prosthetic joint infection.
Level of evidence: 2.
Given the limitations of the preoperative diagnostic work-
up in identifying the presence or absence of infection, fluid
and tissue cultures of the suspected infection site are often
necessary. Twenty-three level 2 studies in our systematic re-
view showed moderate to high sensitivity (43.5–100%) and
high specificity (81.2–100%) for cultures [19, 57, 60, 65, 75,
78, 80, 92, 95–108]. The culture of multiple intraoperative
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tissue samples is important for the differentiation of contami-
nation from infection. Accordingly, we recommend using five
tissue samples for microbial culture for both aerobic and an-
aerobic culturing. Cultures can reliably confirm the etiology of
joint infection in cases where two or more tissue samples
show growth of the same micro-organism. The incubation
time should be at least 7 days, although some studies even
advise an incubation time of 2 weeks [65, 72]. Cultures may
be false-negative due to prior use of an antimicrobial agent,
low number of organisms, use of an inappropriate culture
medium, infection by a fastidious organism, or prolonged
transport time to the microbiology laboratory. Therefore, it is
advisable to stop antibiotic treatment at least 2 weeks before
sampling.
10. Measurement of the synovial biomarkers alpha-
defensin, leukocyte esterase, interleukin-6, and C-
reactive protein is useful in the detection of prosthetic joint
infection.
Level of evidence: 2.
In the last decade, numerous studies have addressed the
evaluation of new biomarkers in synovial fluid. These bio-
markers show promising results. In our systematic review,
alpha-defensin showed very high sensitivity and specificity
(95.5–100% and 95–100%, respectively) in three level 2 stud-
ies and two level 3 studies [62, 68, 109–111]. Alpha-defensin
is produced locally in the joint and does not appear to be
influenced by antibiotic treatment before diagnostic evalua-
tion. However, this test is expensive and not yet available in
every hospital . Some low-grade bacteria such as
Cutibacterium acnes (formerly Propionibacterium acnes)
are less likely to be demonstrated with alpha-defensin mea-
surement. Another synovial biomarker, leukocyte esterase,
has also demonstrated diagnostic value, with sensitivity of
66–100% and specificity of 77–100% in five level 2 studies
[112–116]. Leukocyte esterase is tested on a colorimetric re-
agent pad. It has the advantages of simplicity and of providing
real-time results. Nevertheless, the reagent strip cannot be ad-
equately read in the presence of blood or other debris. IL-6 has
shown better diagnostic performance in synovial fluid than in
serum. Six level 2 studies demonstrated sensitivity of 62.5–
97% and specificity of 85.7–100% [57, 66, 76, 111, 117, 118].
IL-6 promotes osteoclast activation, consequently leading to
prosthetic loosening. The costs are fairly high, and this test is
not available in every hospital. CRP can bemeasured in serum
and in synovial fluid. Synovial CRP showed diagnostic value,
with sensitivity of 70–97.3% and specificity of 78.6–100%, in
eight level 2 studies [62, 77, 79, 81, 111, 118–120]. Routine
laboratory equipment that assays serum CRP can be used for
testing synovial CRP. Non-elevated CRP in synovial fluid
does not rule out PJI, as CRP is produced in the liver and
not in the joints. Care must be taken to take physical exami-
nation and history into account, because CRP is a nonspecific
marker of acute inflammation.
11. Biopsy of periprosthetic tissue for histology and cul-
tures can be performed for preoperative diagnosis in cases
where ESR and/or CRP are positive and aspiration is in-
conclusive or impossible to test (dry tap).
Level of evidence: 2.
Biopsy is not advised in all cases, as it is an invasive diag-
nostic modality. Five papers showed high diagnostic value
(sensitivity 79.1–100%, specificity 90–100%); therefore, bi-
opsy can be used to rule in and rule out infection [66, 67, 81,
121, 122]. Knees are more easily biopsied than hips, as in the
hip, only the neck and head of the prosthesis and the inlay of
the acetabular cup are easily accessible. Moreover, biopsy is
associated with risk of infection and vascular or nerve injury.
Using the blind technique could cause damage such as
scratches to the articulating prosthetic surface. Culturing of
biopsied periprosthetic tissue can identify the causative micro-
organism, and as a result, the correct antimicrobial treatment
and adequate bone cement for the arthroplasty can be chosen.
12. Antibiotic therapy should be postponed or
discontinued before pre- and intraoperative sampling.
Level of evidence: 4.
In clinical practice, the dictum that antibiotics should be
withheld before obtaining microbiological cultures is well
recognised. Some studies have confirmed the impact of pre-
vious antibiotic therapy on the probability of obtaining a mi-
crobiological diagnosis of PJI.
In a prospective trial in 79 patients with PJI, culture of
samples obtained by sonication of the explanted prostheses
were compared with conventional culture of periprosthetic
tissue for the microbiological diagnosis of prosthetic joint in-
fection. The sensitivity of the tissue cultures decreased (from
77% to 48% to 41%) as the antimicrobial-free interval before
surgery decreased (from more than 14 days, to 4–14 days, and
to 0–3 days, respectively) [20]. This was confirmed in another
study, in which the sensitivity of periprosthetic tissue and sy-
novial fluid culture increased from 54% to 73% when the
patients who had received antimicrobial agents were excluded
[93].
Another study found a statistically significant difference in
the rate of positivity of biopsy specimen bacterial cultures
between patients exposed and not exposed to previous antibi-
otic therapy [123].
Similarly, some studies reported higher sensitivity of syno-
vial fluid culture in patients who did not take antibiotics before
the procedure as comparedwith patients exposed to antibiotics
[93, 124].
13. Antibiotic therapy should not be discontinued be-
fore white blood cell scintigraphy.
Level of evidence: 4.
The issue of whether on-going antibiotic treatment may
interfere with the diagnostic accuracy of WBC scintigraphy
has beenwidely disputed, yet there are no clinical comparative
studies in patients with and without antibiotic treatment.
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Therefore, this information can only be extrapolated indirectly
from studies that have included patients at diagnosis treated
with antibiotics or from studies in patients during follow-up of
therapy. Indeed, there are a number of studies of this kind in
osteomyelitis (including peripheral bone osteomyelitis, pros-
thetic joint infection, and diabetic foot osteomyelitis)
[125–131], soft tissue infections [132–136], inflammatory
bowel diseases [137, 138], and cardiovascular infection
[139, 140]. If taken together, approximately half of them con-
clude that antibiotic treatment reduces diagnostic accuracy
[131, 135, 136, 138], and the other half report that it does
not [125–130, 132, 137, 139]. This is based on the pooled
sensitivity and specificity that seems to be reduced or unaf-
fected with respect to patients at diagnosis without antibiotic
therapy. Nevertheless, if we look only at only those papers in
which the final diagnosis was made by histological evaluation
of bone biopsy, we may conclude that WBC scintigraphy has
the same diagnostic accuracy either before or during antibiotic
treatment. This is particularly convincing for the diabetic foot
infection [129, 130] and less convincing for prosthetic joint
infections, mainly because of the results obtained by Chik
et al. [131].
In summary, there is not sufficient evidence in the literature
to reach a definitive conclusion on the impact of antibiotic
treatment on the accuracy of WBC scintigraphy in PJI.
14. Computed tomography can be effectively used to
diagnose PJI.
Level of evidence: 2.
Computed tomography has traditionally been used to eval-
uate orthopaedic implants. Striking artefacts caused by the
interaction of the x-ray beam with the metallic hardware are
now markedly reduced thanks to recent technical improve-
ments. On CT, joint distension, fluid-filled bursae, and soft
tissue collections are the main findings. Cyteval et al. reported
that CT demonstrated 100% sensitivity, 87% specificity, and
89% accuracy when at least one soft tissue abnormality was
used as an infection criterion, and 83% sensitivity, 96% spec-
ificity, and 94% accuracy when joint distention was used as
infection criterion [141]. Absence of joint distension had 96%
negative predictive value. Fluid collection in muscles and
peri-muscular fat demonstrated 100% positive predictive val-
ue. Periosteal new bone has shown high specificity (100%)
but low sensitivity (16%) for infection. Bone lucency around
the implant is not a criterion for diagnosing infection, although
in infected patients, CT may demonstrate a Bmore aggressive,
ill-defined^ lucency [142, 143]. Detection of a sinus tract may
be difficult on CT.
15. The diagnostic accuracy for three-phase bone scin-
tigraphy in patients with suspected infection within the
first 2 years after hip or knee prosthesis placement is low.
Level of evidence: 2.
Three-phase bone scintigraphy is the most widely
used screening modality for the diagnosis of PJI.
However, it is common knowledge that the technique
is highly sensitive but has low specificity for PJI, since
any cause of increased bone formation (e.g. physiologi-
cal bone remodelling or aseptic prosthetic loosening)
shows increased periprosthetic activity on the bone scan.
This physiological bone remodelling probably takes
place in the first years after joint replacement surgery
and is also dependent on the type of prosthesis and
whether the prosthesis was cemented or uncemented.
The results of our search yielded 89 papers, of which
14 were included. After reading these papers thorough-
ly, we included only five papers that investigated the
role of three phases in bone scan after joint replacement
[144–148], four of which were reviews/overviews/expert
opinions, and only one paper [144] reported the exact
time between first surgery and bone scan (median dura-
tion 21 months in 39 patients after a unicompartmental
knee replacement [UKR]). The authors found sensitivity
of 50% and specificity of 71% for infection and con-
cluded that there is no evidence to support the routine
use of bone scan in clinical decision-making for patients
with a painful UKR.
Experts agree that the diagnostic accuracy for three-
phase bone scan in patients with suspected infections
within the 5 years after hip or knee prosthesis place-
ment is low. Van der Bruggen et al. [43] mention that
in post-traumatic patients and after surgery, specificity is
extremely low, around 35%. During this period, it is
better to immediately perform another imaging tech-
nique, preferably white blood cell scintigraphy.
16. In the case of negative three-phase bone scintigra-
phy, a diagnosis of prosthetic joint infection can be
excluded.
Level of evidence: 2.
Bone scintigraphy is widely used as first imaging modality
when there is suspicion of a low-grade PJI. All three phases
(perfusion, blood pool, and late phase depicting the osteoblas-
tic activity) are necessary when an infection is suspected.
Although a positive bone scan can be the result of any cause
of increased osteoblast activity, a negative bone scan in all
three phases means that there is no increased perfusion and
no increased osteoblastic activity. It has been stated, therefore,
that a negative three-phase bone scan rules out a diagnosis of
PJI.
We conducted a literature search and 76 papers were re-
trieved, of which 15 were eventually included for thorough
reading.
Only four research studies focused on the negative
predictive value of the three-phase bone scan. Ikeuchi
et al. [149] investigated the role of the bone scan in 15
patients after joint arthroplasty. They concluded that
when the three-phase bone scan is negative, residual
infection around the cement spacer is unlikely. Nagoya
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et al. [150] concluded that a negative three-phase bone
scan suggests a low probability of periprosthetic infec-
tion and that one-stage revision could be considered in
these cases. Volpe et al. [151] showed that a diagnostic
algorithm using bone scan as a first screening modality
had high diagnostic accuracy. Unfortunately, only seven
patients had a negative bone scan, and timing between
primary surgery and scans was not mentioned. Trevail
et al. [152] investigated an imaging algorithm in 235
consecutive patients, of which only 17 were ultimately
diagnosed with a proven infection. The authors also
initially performed a bone scan. If the bone scan was
negative, then infection was excluded and no WBC scan
was performed. Using this algorithm, they found sensi-
tivity of 80% and specificity of 99.5%. They did not
mention, however, how many patients had a negative
bone scan and in how many patients a WBC scan was
performed.
Other included papers (overviews, reviews, and expert
opinion) are in agreement that a study with normal findings
(no increased perfusion or blood pool, no periprosthetic up-
take in the late phase) can be considered strong evidence
against the presence of an infection [146, 153–156].
17. In the case of a positive three-phase bone scan, the
addition of white blood cell scintigraphy leads to high di-
agnostic accuracy for PJI.
Level of evidence: 2.
A positive three-phase bone scintigraphy can have several
causes, including PJI, physiological bone remodelling, or
aseptic loosening of the prosthesis. Therefore, other investiga-
tions must be performed to further differentiate between infec-
tion, reactive changes, and loosening. To determine whether
WBC scintigraphy, when added to the diagnostic flowchart of
a positive three-phase bone scintigraphy, leads to higher diag-
nostic accuracy, we conducted a PubMed search with the fol-
lowing terms: B(prosthetic OR prosthesis OR joint infection))
AND (bone scan OR MDP OR HDP OR bone scintigraphy))
AND (WBC scan ORWBC scintigraphy OR white blood cell
scan OR white blood cell scintigraphy OR leukocyte scintig-
raphy)) AND diagnosis of infection^; 44 papers were re-
trieved, of which 19 were eventually included for thorough
reading.
Only two research papers were found that specifically stud-
ied whether the addition of WBC scintigraphy after a positive
bone scan leads to high diagnostic accuracy. Volpe et al. [149]
showed that a diagnostic algorithm using the bone scan as first
screening modality, and, when positive, the LeukoScan,
achieved high diagnostic accuracy. Unfortunately, only seven
patients had a negative bone scan, and timing between surgery
and scans was not mentioned. Trevail et al. [152] also inves-
tigated an imaging algorithm in 235 consecutive patients, of
which only 17 were ultimately diagnosed with a proven infec-
tion. The authors also performed an initial bone scan, which, if
positive, was followed with a WBC scan. The use of this
algorithm led to sensitivity of 80% and high specificity of
99.5%. Not mentioned, however, was how many patients
had a negative bone scan and in how many patients a WBC
scan was performed.
We also agree that another imaging modality is necessary
in the case of a positive three-phase bone scan in patients with
suspected PJI [3, 43, 157–160], and that WBC scintigraphy is
the first nuclear imaging modality of choice in these cases
because of its high diagnostic accuracy.
18. In the case of negative white blood cell scintigraphy,
the probability of prosthetic joint infection is low.
Level of evidence: 2.
WBC scintigraphy has been described by many authors as
highly sensitive and very specific for the diagnosis of PJI.
However, there is still some concern whether low-grade
chronic PJI with small amounts of bacteria on the biofilm
can lead to false-negative WBC scan results.
We conducted a literature search to look at the diag-
nostic accuracy of WBC scintigraphy in patients with
suspected PJI, and we retrieved 97 papers, of which
20 were eventually included for thorough reading and
12 after thorough reading.
The largest patient series included is from Kim et al.
[161], who found NPV of 92% in 164 patients with
suspected PJI (71 hip, 93 knee). Glaudemans et al. [154]
used a time-decay dual-time-point imaging protocol and
found NPVof 94% in 67 patients with suspected hip pros-
thesis infection, and NPV of 96% in 71 patients with
suspected knee prosthesis infection. The same protocol
was used by Erba et al. [162]. They report NPV of 93%
in both hip and knee prostheses in 44 and 40 patients,
respectively. Older studies used other protocols, including
WBC labelled with 111In or anti-granulocyte imaging, or a
combination of WBC/bone marrow (BM) scintigraphy.
Sousa et al. [163] report NPV NPV of 100% using
sulesomab. Jung et al. [164] found NPV of 100%, but this
was in only 11 patients and using a combined imaging proto-
col (WBC/BM). Simonsen et al. used both 99mTc- and 111In-
labelled WBC, and found 94% true-negative results [165].
Only Basu et al. found lower NPV (85% in patients with
suspected hip prosthesis infection), but they used an incorrect
acquisition protocol with only one imaging time point be-
tween 18 and 24 h after re-injection [166]. In conclusion,
expert opinions and most research studies indicate high nega-
tive predictive value for WBC scintigraphy, which is even
higher when performed with the correct acquisition protocol
and interpretation criteria.
19. 18F-FDG-PET in patients with suspected prosthetic
joint infection has high sensitivity but lower specificity
than white blood cell scintigraphy or anti-granulocyte an-
tibody scintigraphy.
Level of evidence: 2.
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A PubMed search based on the above-listed MeSH terms
revealed 15 papers, of which five (three original research ar-
ticles and two systematic reviews) were selected for thorough
reading. In addition, four papers on the diagnostic perfor-
mance ofWBC scintigraphy in prosthetic joint infections were
added.
There are few articles directly comparing the diagnostic
performance of FDG-PET and WBC scintigraphy. The study
by Love et al. [34] reported significantly higher accuracy for
combined bonemarrow andWBC scintigraphy than for FDG-
PET, independent of the interpretation criteria used for FDG-
PET. Vanquickenborne et al. [167] reported similar sensitivity
between WBC scintigraphy and FDG-PET (88%), but higher
specificity forWBC scan comparedwith FDG-PET (100% vs.
78%). The study by Pill et al. [168] reported sensitivity and
specificity of 95% and 93%, respectively, for FDG-PET, while
the use of combined 99mTc-sulfur colloid- and 111In-labelled
WBC demonstrated sensitivity of 50% and specificity of 95%.
Reinartz et al. [32], in a systematic review, reported higher
sensitivity but lower specificity for FDG-PET compared with
WBC scintigraphy. In addition, the accuracy for FDG-PET
was found to be slightly higher in hip prosthesis than in knee
prosthesis. In another review article, Gemmel et al. reported
pooled sensitivity and specificity of 84% for FDG-PET in PJI,
with higher accuracy for hip than knee prosthesis [31]. The
joint EANM/SNMMI guidelines for the use of FDG in inflam-
mation and infection (expert opinion) reported overall sensi-
tivity of 95% for FDG-PET and specificity of 98% for knee
and hip PJI [160].
In all mentioned systematic reviews, the range for both
sensitivity (28–91%) and specificity (34–97%) in the individ-
ual studies was quite large. This is largely attributable to the
differences in study design and interpretation criteria (visual
interpretation using pattern recognition), emphasizing the
need for standardized reconstruction and interpretation
criteria.
Although there are not many published papers that directly
compare FDG-PET and WBC scintigraphy in prosthetic joint
infections, several different interpretation criteria for FDG-
PET have been tested, and all papers confirm the lower spec-
ificity of FDG-PET compared with WBC scintigraphy. Large
prospective studies comparing the diagnostic performance of
WBC scintigraphy and FDG-PET for prosthetic joint infec-
tions are anticipated.
20. Anti-granulocyte scintigraphy is a good alternative
to white blood cell scintigraphy, with similar sensitivity
and specificity (mentions human anti-mouse antibodies
[HAMA], differences between Fab and IgG, repeatability,
which one to use in function of pretest probability, etc.).
Level of evidence: 2.
An extensive PICO was performed using a combination of
different terms, but no papers were found that directly com-
pared the diagnostic accuracy of labelled white blood cells
with anti-granulocyte antibodies for patients with suspicion
of prosthetic joint infections. A direct comparison between
99mTc-besilesomab- and 99mTc-labelled white blood cells in
peripheral osteomyelitis, including patients with PJI, was pub-
lished by Richter et al. [169], with comparable results for the
two imaging approaches [163, 170].
Two meta-analyses on the diagnostic performance of anti-
granulocyte antibodies in prosthetic joint infections were per-
formed by Pakos et al. [171] and Xing et al. [172], and re-
vealed overall sensitivity of 83% and specificity of 79–80%.
These results are comparable to radiolabelled white blood
cells, with slightly lower specificity for antibodies.
Considering the results of these meta-analyses, the use of
anti-granulocyte antibodies can be regarded as a valid alterna-
tive in patients with suspicion of prosthetic joint infections.
21. Hybrid SPECT/CT imaging can improve localiza-
tion of infection (and diagnostic accuracy).
Level of evidence: 2.
Since the introduction of hybrid imaging technologies in
clinical practice, the diagnostic accuracy of conventional nu-
clear exams has drastically improved due to the complemen-
tary molecular/functional and morphological information.
Even though current recommendations for interpreting white
blood cell scintigraphy are based solely on planar images at
consecutive time points, adding SPECT/CT in the case of a
positive result would theoretically further increase the diag-
nostic accuracy. It is well established for other pathologies that
adding SPECT/CT to planar images results in higher diagnos-
tic accuracy because of better resolution and morphological
information.
A PubMed search yielded 50 papers, of which five papers
(three original research articles [161, 173, 174] and two sys-
tematic reviews [31, 175]) were included. Two small studies
[173, 174] showed increased specificity for SPECT/CT com-
pared with SPECTalone and demonstrated contributory value
in up to 38%. The largest study, by Kim et al., also demon-
strated improved diagnostic accuracy with the addition of
SPECT/CT [161].
Despite limited published data on white blood cell SPECT/
CT in patients with suspicion of prosthetic joint infections, the
incremental value of SPECT/CT over planar imaging is obvi-
ous. Adding SPECT/CT increases diagnostic accuracy by bet-
ter distinguishing bone infection from soft tissue infections
through improved assessment of the extent of the infection.
Therefore, SPECT/CT should be recommended in the case of
a positive planar white blood cell scan.
22. Semiquantitative analysis of WBC accumulation
over time in WBC scan increases diagnostic accuracy for
PJI.
Level of evidence: 3.
Based on the assumption that radiolabelled WBC, once
injected into the patient, will migrate over time to an
infected area and will progressively accumulate there
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due to the presence of chemotactic factors, nuclear medi-
cine physicians have thought to quantify the presence of
WBC in suspected lesions at 3–4 h after injection and
again at 20–24 h. This quantitation is expressed as a ratio
between radioactivity in the suspected region (target) and
radioactivity in a background area. If this target-to-
background (T/B) ratio increases over time (i.e.
T/B20h > T/B4h), there is active WBC accumulation, which
is interpreted as an infection. By contrast, if the ratio
decreases over time (i.e. T/B20h < T/B4h), there is only
transient WBC accumulation in the lesion, and it is
interpreted as a sterile inflammatory process. Only two works
have systematically investigated these assumptions, however,
in retrospective studies, using the histological/microbiological
information or long-term clinical follow-up of patients as gold
standard [154, 176]. Both studies demonstrated a clear im-
provement in diagnostic accuracy for the semiquantitative
method over simple qualitative image evaluation, particularly
if the calculation of the T/B ratio was performed in both de-
layed images (3-4 h) and late images (20-24 h), and if the
contralateral tissue was used as background instead of the
ipsilateral bone marrow or ipsilateral iliac bone (often not
available in the case of knee prosthesis). Glaudemans et al.
showed that the T/B should show an increase of at least 10%
to be considered a reliable indicator of granulocyte accumula-
tion over time [154].
Other studies have applied a similar semiquantitative meth-
od, not only for prosthesis infection but also for soft tissue
infection [161], post-traumatic osteomyelitis [176], and dia-
betic foot infection [35], or even with other radiopharmaceu-
ticals such as FDG [34, 35, 177]. All studies were in agree-
ment on the usefulness of semiquantitative evaluation of
WBC accumulation in infected lesions over time. In particular,
VanAcker et al. [178] emphasized that when only a qualitative
approach is used, there is no benefit regardless of whether the
analysis is done with or without a grading. It is worth men-
tioning that a study by Glaudemans et al. in a large number of
patients demonstrated that semiquantitative analysis of the T/
B ratio was particularly useful in those cases with a doubtful
qualitative interpretation [154].
23. Combining WBC scan with bone marrow scan in-
creases diagnostic accuracy for PJI detection.
Level of evidence: 2.
The use of combined WBC scintigraphy (using either
99mTc-HMPAO-WBCor 111In-oxine-WBC) and bonemarrow
scintigraphy (with radiolabelled colloids) has been studied by
Fig. 1 The suggested initial diagnostic steps to undertake in the case of
suspicion of a PJI, based on published evidence. Some tests can be
repeated (i.e. blood cultures, bone biopsies, or soft tissue biopsies).
Serological tests (CRP, WBC count with differential, and ESR) should
be performed over time, since the overall increasing or decreasing trend is
more important than a single value. The choice of an advanced diagnostic
test depends on availability, costs, radiation burden, and operator
experience (see Tables 1 and 2). Synovial biomarkers and cultures can
be better performed after sonication of tissue samples. They have high
accuracy for infection but need to be integrated with advanced imaging
modalities to study the bone and soft tissue status and the extent and
severity of the infection
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many authors. This technique allows us to reduce the number
of false-positive cases at WBC scintigraphy due to WBC ac-
cumulation in areas of expanded/displaced bone marrow by
providing a map of bone marrow activity. It is particularly
useful in cases of suspected PJI and in patients with a doubtful
qualitative or semiquantitative analysis of WBC scintigraphy.
With few exceptions, the cumulative results obtained from
papers describing this combined technique are remarkably
consistent, with reported diagnostic accuracy ranging from
83% to 98% for both 111In-oxine-WBC and 99mTc-HMPAO-
WBC and for both hip and knee prosthesis infections [31, 34,
155, 165, 179–183]. Pill et al. in 2006 [168] and Joseph et al.
in 2001 [184] reported low sensitivity (50% and 46%, respec-
tively) but very high specificity (95% and 100%, respective-
ly). The reason for the low sensitivity in these studies was that
most of the examined infections were subacute or chronic,
and/or microbiological data were often lacking. Given these
few exceptions, it appears that combined in vitro labelled
leucocyte/bone marrow scintigraphy (LS/BMS) has overall
diagnostic accuracy of >90% and is the imaging modality of
choice for diagnosing PJI.
Most importantly, the acquisition protocol and the interpre-
tation criteria for WBC scintigraphy differed dramatically in
the reported studies, thus emphasizing the importance of the
combined LS/BMS technique.
Today, standardized acquisition and interpretation criteria
are being disseminated and utilised across Europe, thus further
reducing inter-observer variability and increasing the diagnos-
tic accuracy and reproducibility of WBS scintigraphy. This
will certainly help to reduce the number of doubtful cases in
which to apply additional BMS scintigraphy.
24. MRI is wholly feasible in patients with suspected
PJI.
Level of evidence: 2.
The presence of a joint prosthesis does not represent a
contraindication to MRI. Traditionally, joint implants were
considered potentially limiting to the outcome of an MR ex-
amination, due to a high quantity of susceptibility artefacts
that could be generated by the metal itself. More recently,
the advent of prostheses made with less ferromagnetic alloy
materials and the technological advancements in MR se-
quences (metal artefact reduction sequences [MARS], slice
encoding for metal artefact correction [SEMAC], and multi-
acquisition with variable-resonance image combination
[MAVRIC]) have made MRI wholly feasible in patients with
joint implants, with artefacts largely confined to the area of the
implant itself [185–187]. The diagnostic performance of MRI
in PJI is addressed in statement 25.
25. MRI demonstrates high diagnostic performance in
detecting clinically suspected PJI, with no ionizing
radiation.
Level of evidence: 2.
Despite the widespread use of this protocol in clinical
practice, most papers on MRI and joint prosthesis were
3-phase bone scan or FDG-PET1
More than 2 years after prosthesis implant Within 2 years after prosthesis implant
Positive Negative 
Negative Positive 
No infection No infection Infection
WBC scan (with or w/out 
bone-marrow scan2
Suspicion of acute 
infection: WBC 
scan2 (or AGA scan2) 
Suspicion of chronic 
infection: AGA scan2
(or WBC scan2) 
Negative Positive 
Fig. 2 The suggested path to undertake when nuclear medicine
procedures are considered for suspicion of a PJI, based on published
evidence and expert opinion. Initial stratification is based on time after
implant (more or less than 2 years). This is particularly true for hip and
shoulder prostheses, but knee prosthesis may require up to 5 years post-
implant to reduce physiological inflammation. Some differencesmay also
depend on the type of prosthesis (cemented or not), with cemented pros-
theses having a shorter post-implant time for physiological inflammatory
reaction. 1FDG-PET has higher sensitivity than specificity, mainly be-
cause of false-positive inflammatory uptake in the case of aseptic loosen-
ing and/or recent surgery. This is why it is better to exclude an infective
process in chronic painful joints. Nevertheless, despite the lack of stan-
dardized image interpretation criteria available, FDG-PET has also been
proposed in early acute phases of infections. 2WBC scan has higher
sensitivity and specificity than AGA scan, FDG-PET, and MRI, and is
preferred when available and indicated for the patient. The methodology
for these nuclear medicine scans is extremely important (usually by ac-
quiring three sets of images corrected for isotope decay), and we refer to
the procedural guidelines published by the EANM Committee on
Infection/Inflammation. It can be combined with bone marrow scintigra-
phy to further increase specificity
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focused on the technical feasibility of this examination.
Only three papers specifically aimed to evaluate prosthe-
sis infection. In the knee, Plodowski et al. found 86–92%
sensitivity and 85–87% specificity for infection, while Li
et al. found 65–78% sensitivity and 98–99% specificity.
In the hip, He et al. found 94% sensitivity and 97% spec-
ificity. Like ultrasound, MRI is an imaging modality that
does not use ionizing radiation. This fact should be given
particular consideration, especially in these patients, who
typically need repeated examinations [44–47].
Conclusions and final recommendations
The proposed flowchart is shown in Fig. 1. Regarding the
advanced diagnostic tests, there are too few well-designed
papers (with a high level of evidence) that directly compare
radiological and nuclear medicine techniques. When choosing
an advanced diagnostic test, further stratification should be
performed based on the pretest probability of infection and
local availability and experience. Overall, considering the di-
agnostic performance of all modalities, both WBC scan (with
or without bone marrow scan) or anti-granulocyte scintigra-
phy (preferably with IgG) and non-contrast MRI can be per-
formed as an initial investigation (Fig. 2).
Evidence-based diagnostic flow charts
Based on the above-mentioned statements and evidence from
the published literature, we have developed a diagnostic flow
chart, shown in Fig. 1, correlated with Tables 1 and 2.
In some cases, the flow was integrated by consensus opin-
ion amongst the experts, since not all steps are always clearly
deducible from the literature or from level 1–2 articles. The
flow chart does not take into consideration socioeconomic
factors or the availability of diagnostic methods. It also pre-
sumes that all exams are optimally performed (possibly
Table 1 Advanced radiological techniques
Ultrasound Computed tomography Magnetic resonance
Pros May be useful in monitoring soft
tissue extension of infection and
for soft tissue biopsies
Widely available and low cost
Needed as a guide for bone biopsy
Widely available and medium cost
High diagnostic accuracy using new
sequences without interference from the
prosthesis
Widely available and medium cost
Radiation-free
Cons Low sensitivity and specificity for
bone infection
Possible striking artefacts due to the metal
nature of prosthesis
Overall lower diagnostic accuracy than
MR
High radiation exposure
Possible side effects from contrast agent
Peri-implant edema may occasionally suggest
false-positive findings
Table 2 Advanced nuclear medicine techniques
99mTc-MDP/HDP bone scan 99mTc-anti-granulocyte scan (IgG/Fab AGA) 99mTc-HMPAO/111In-oxine-WBC scan [18F]FDG-PET/CT
Pros High sensitivity
Useful as screening method in
chronic infections
Widely available and low cost
High sensitivity and specificity; however,
generally lower than for WBC scan
Data support the preferential use of IgG over
Fab in chronic infections. Widely available
and medium cost
Often to be used coupled with bone marrow
scan and/or bone scan
High sensitivity and specificity
Data support preferential use in acute
infections
Poor availability and medium cost
Often to be used coupled with bone
marrow scan
SPECT/CT images improve accuracy
High sensitivity
Cons Low specificity
Moderate radiation exposure
Possible contraindications for IgG and
HAMA induction
Moderate radiation exposure
IgG scan requires a late acquisition at 20 h p.i.
Moderate radiation exposure
Always requires a late acquisition at 20 h
p.i.
Blood manipulation
Needs an approved laboratory and
method and trained personnel
Low specificity
High radiation
exposure
Difficult
interpretation of
images
Poor availability and
high cost
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following procedural guidelines published by each European
or national society, when available) and by expert
professionals.
Acknowledgements Alberto Signore, Andor WJM Glaudemans, and
Olivier Gheysens are representatives of the European Association of
Nuclear Medicine (EANM); Luca Maria Sconfienza, Victor Cassar-
Pullicino, and Filip MHM Vanhoenacker are representatives of the
European Society of Radiology (ESR); Olivier Borens, Heinz Winkler,
and Paul C. Jutte are representatives of the European Bone and Joint
Infection Society (EBJIS); Andrej Trampuz and Nicola Petrosillo are
representatives of the European Society of Clinical Microbiology and
Infectious Diseases (ESCMID).
We wish to thank the many people who contributed to these guidelines
by actively working on them or just contributing with useful discussion:
first of all, the members of the EANM Committee on Infection and
Inflammation (Elena Lazzeri, Riddhika Chakravarrty, Chiara Lauri,
Vera Artico, Andrè Diaz, Samantha Terry, Paola Erba, and John
Buscombe) and the important advice we received from other committees,
and in particular the Bone & Joint Committee, the Radiopharmacy
Committee, and the Technologist Committee of EANM.
We also thank the boards of ESR, EBJIS, and ESCMID for supporting
this work and the dissemination of our results in international congresses.
We thank Claudia Löwik for performing a literature search and retrieving
articles.
Each practice guideline, representing a policy statement, has under-
gone a thorough consensus process in which it has been subjected to
extensive review. EANM/ESR/EBJIS and ESCMID recognize that the
safe and effective use of diagnostic imaging requires specific training,
skills, and techniques, as described in each document.
This guideline was brought to the attention of all other EANM com-
mittees and to the national societies of nuclear medicine. The comments
and suggestions from the Oncology Committee, the Radiation Protection
Committee, and the Translational-Molecular Imaging Committee, and
from the Czech Republic, Italian, Latvian, Russian, German, and Polish
national societies are highly appreciated and have been considered for this
Guideline.
Compliance with ethical standards
Conflict of interest The authors declare that they have no conflict of
interest.
Ethical approval This article does not contain any studies with human
participants performed by any of the authors. For this type of study,
formal consent is not required.
Disclaimer The European Association of Nuclear Medicine (EANM)
has written and approved guidelines to promote the use of nuclear med-
icine procedures of high quality. The guidelines should not be deemed
inclusive of all proper procedures and exclusive of other procedures rea-
sonably directed to obtaining the same results.
The facilities in a specialized practice setting may be different from
those in a more general setting. Resources available to care for patients,
legislation, and local regulations may vary greatly from one European
country or one medical facility to another. For these reasons, these guide-
lines cannot be rigidly applied.
Open Access This article is distributed under the terms of the Creative
Commons At t r ibut ion 4 .0 In te rna t ional License (h t tp : / /
creativecommons.org/licenses/by/4.0/), which permits unrestricted use,
distribution, and reproduction in any medium, provided you give appro-
priate credit to the original author(s) and the source, provide a link to the
Creative Commons license, and indicate if changes were made.
Publisher’s note Springer Nature remains neutral with regard to juris-
dictional claims in published maps and institutional affiliations.
References
1. Kurtz S, Mowat F, Ong K, Chan N, Lau E, HalpernM. Prevalence
of primary and revision total hip and knee arthroplasty in the
United States from 1990 through 2002. J Bone Joint Surg Am.
2005;87:1487–97.
2. Kurtz SM, Lau E, Watson H, Schmier JK, Parvizi J. Economic
burden of periprosthetic joint infection in the United States. J
Arthroplast. 2012;27:61–5.
3. Glaudemans AW, Galli F, Pacilio M, Signore A. Leukocyte and
bacteria imaging in prosthetic joint infection. Eur Cell Mater.
2013;25:61–77.
4. Cataldo MA, Petrosillo N, Cipriani M, Cauda R, Tacconelli E.
Prosthetic joint infection: recent developments in diagnosis and
management. J Inf Secur. 2010;61:443–8.
5. Trampuz A, Zimmerli W. Prosthetic joint infections: update in
diagnosis and treatment. Swiss Med Wkly. 2005;135(17–18):
243–51.
6. Berbari EF, Hanssen AD, DuffyMC, Steckelberg JM, Ilstrup DM,
Harmsen WS, et al. Risk factors for prosthetic joint infection:
case-control study. Clin Infect Dis. 1998;27(5):1247–54.
7. Zimmerli W, Trampuz A, Ochsner PE. Prosthetic-joint infections.
N Engl J Med. 2004;351(16):1645–54.
8. Moran E, Masters S, Berendt AR, McLardy-Smith P, Byren I,
Atkins BL. Guiding empirical antibiotic therapy in orthopaedics:
the microbiology of prosthetic joint infectionmanaged by debride-
ment, irrigation and prosthesis retention. J Inf Secur. 2007;55(1):
1–7.
9. Hsieh PH, Lee MS, Hsu KY, Chang YH, Shih HN, Ueng SW.
Gram-negative prosthetic joint infections: risk factors and out-
come of treatment. Clin Infect Dis. 2009;49(7):1036–43.
10. Legout L, Senneville E, Stern R, Yazdanpanah Y, Savage C,
Roussel-Delvalez M, et al. Treatment of bone and joint infections
caused by gram-negative bacilli with a cefepime-fluoroquinolone
combination. Clin Microbiol Infect. 2006;12(10):1030–3.
11. Sia IG, Berbari EF, Karchmer AW. Prosthetic joint infections.
Infect Dis Clin N Am. 2005;19(4):885–914.
12. Berbari EF, Marculescu C, Sia I, Lahr BD, Hanssen AD,
Steckelberg JM, et al. Culture-negative prosthetic joint infection.
Clin Infect Dis. 2007;45(9):1113–9.
13. Marculescu CE, Berbari EF, Cockerill FR 3rd, Osmon DR. Fungi,
mycobacteria, zoonotic and other organisms in prosthetic joint
infection. Clin Orthop Relat Res. 2006;451:64–72.
14. Jutte P, Lazzeri E, Sconfienza LM, Cassar-Pullicino V, Trampuz
A, Petrosillo N, et al. Diagnostic flowcharts in osteomyelitis,
spondylodiscitis and prosthetic joint infection. Q J Nucl Med
Mol Imaging. 2014;58:2–19.
15. Howick J, Chalmers I, Glasziou P, GreenhalghT, Heneghan C,
Liberati A, Moschetti I, Phillips B, Thornton H. The 2011
Oxford CEBM levels of evidence (introductory document).
Oxford Centre for Evidence-Based Medicine. 2011.
16. OCEBM Levels of Evidence Working Group. The Oxford 2011
Levels of Evidence. Oxford Centre for Evidence-Based Medicine.
www.cebm.net/index.aspx?0=5653. website. 2016.
17. Trampuz A, Steckelberg JM, Osmon DR, Cockerill FR, Hanssen
AD, Patel R. Advances in the laboratory diagnosis of prosthetic
joint infection. Rev Med Microbiol. 2003;14:1–14.
18. Pandey R, Berendt AR, Athanasou NA. Histological and micro-
biological findings in non-infected and infected revision
arthroplasty tissues. The OSIRIS collaborative study group.
Eur J Nucl Med Mol Imaging
Oxford Skeletal Infection Research and Intervention Service. Arch
Orthop Trauma Surg. 2000;120(10):570–4.
19. Spangehl MJ, Masri BA, O’Connell JX, Duncan CP. Prospective
analysis of preoperative and intraoperative investigations for the
diagnosis of infection at the sites of two hundred and two revision
total hip arthroplasties. J Bone Joint Surg. 1999;81(5):672–83.
20. Trampuz A, Piper KE, Jacobson MJ, Hanssen AD, Unni KK,
Osmon DR, et al. Sonication of removed hip and knee prostheses
for diagnosis of infection. N Engl J Med. 2007;357(7):654–63.
21. Trampuz A, Zimmerli W. Diagnosis and treatment of implant-
associated septic arthritis and osteomyelitis. Curr Infect Dis Rep.
2008;10(5):394–403.
22. Klauser AS, Tagliafico A, Allen GM, Boutry N, Campbell R,
Grainger A, et al. Clinical indications for musculoskeletal ultra-
sound: a Delphi-based consensus paper of the European Society of
Musculoskeletal Radiology. Eur Radiol. 2012;22(5):1140–8.
23. Lee YH, Lim D, Kim E, Kim S, Song H-T, Suh J-S. Usefulness of
slice encoding for metal artifact correction (SEMAC) for reducing
metallic artifacts in 3-T MRI. Magn Reson Imaging. 2013;31(5):
703–6.
24. Li AE, Sneag D, Greditzer HG 4th, Johnson CC, Miller TT, Potter
HG. Total knee arthroplasty: diagnostic accuracy of patterns of
synovitis at MR imaging. Radiology. 2016;27:152828.
25. Plodkowski AJ, Hayter CL, Miller TT, Nguyen JT, Potter HG.
Lamellated hyperintense synovitis: potential MR imaging sign of
an infected knee arthroplasty. Radiology. 2013;266(1):256–60.
https://doi.org/10.1148/radiol.12120042.
26. Van den Wyngaert T, Strobel K, Kampen WU, Kuwert T, van der
Bruggen W, Mohan HK, et al. The EANM practice guidelines for
bone scintigraphy. Eur J Nucl Med Mol Imaging. 2016;43(9):
1723–38. https://doi.org/10.1007/s00259-016-3415-4.
27. De Vries EF, RocaM, Jamar F, Israel O, Signore A. Guidelines for
the labelling of leucocytes with (99m)Tc-HMPAO. Inflammation/
infection Taskgroup of the European association of Nuclear
Medicine. Eur J Nucl Med Mol Imaging. 2010;37:842.
28. Roca M, EFJ DV, Jamar F, Israel O, Signore A. Guidelines for the
labelling of leucocytes with 111In-oxine. Eur J Nuclear Med
Molec Imag. 2010;37(4):835–41 Erratum to: (2010) European
Journal of Nuclear Medicine and Molecular Imaging, 37 (6), p.
1236.
29. Gratz S, Reize P, Kemke B, Kampen WU, Luster M, Höffken H.
Targeting osteomyelitis with complete [99mTc]besilesomab and
fragmented [99mTc]sulesomab antibodies: kinetic evaluations. Q
J Nucl Med Mol Imaging. 2016;60(4):413–23.
30. Jin H, Yuan L, Li C, Kan Y, Hao R, Yang J. Diagnostic perfor-
mance of FDG PET or PET/CT in prosthetic infection after
arthroplasty: a meta-analysis. Q J Nucl Med Mol Imaging.
2014;58:85–93.
31. Gemmel F, Van den Wyngaert H, Love C, Welling MM, Gemmel
P, Palestro CJ. Prosthetic joint infections: radionuclide state-of-
the-art imaging. Eur J Nucl Med Mol Imaging. 2012;39(5):892–
909.
32. Reinartz P. FDG-PET in patients with painful hip and knee
arthroplasty: technical breakthrough or just more of the same. Q
J Nucl Med Mol Imaging. 2009;53(1):41–50.
33. Chacko TK, Zhuang H, Stevenson K, Moussavian B, Alavi A.
The importance of the location of fluorodeoxyglucose uptake in
periprosthetic infection in painful hip prostheses. Nucl Med
Commun. 2002;23(9):851–5.
34. Love C, Marwin SE, Tomas MB, Krauss ES, Tronco GG,
Bhargava KK, et al. Diagnosing infection in the failed joint re-
placement: a comparison of coincidence detection 18F-FDG and
111In-labeled leukocyte/99mTc-sulfur colloid marrow imaging. J
Nucl Med. 2004;45(11):1864–71.
35. Familiari D, Glaudemans AW, Vitale V, Prosperi D, Bagni O,
Lenza A, et al. Can sequential 18F-FDG PET/CT replace WBC
imaging in the diabetic foot? J Nucl Med. 2011;52(7):1012–9.
36. Stumpe KD, Nötzli HP, Zanetti M, Kamel EM, Hany TF, Görres
GW, et al. FDG PET for differentiation of infection and aseptic
loosening in total hip replacements: comparisonwith conventional
radiography and three-phase bone scintigraphy. Radiology.
2004;231(2):333–41.
37. Wenter V, Müller JP, Albert NL, Lehner S, Fendler WP,
Bartenstein P, et al. The diagnostic value of [(18)F]FDG PET
for the detection of chronic osteomyelitis and implant-associated
infection. Eur J Nucl Med Mol Imaging. 2016;43(4):749–61.
38. Thang SP, Tong AK, Lam WW, Ng DC. SPECT/CT in musculo-
skeletal infections. SeminMusculoskelet Radiol. 2014;18(2):194–
202.
39. Tam HH, Bhaludin B, Rahman F, Weller A, Ejindu V, Parthipun
A. SPECT-CT in total hip arthroplasty. Clin Radiol. 2014;69(1):
82–95.
40. Mariani G, Bruselli L, Kuwert T, KimEE, Flotats A, Israel O, et al.
A review on the clinical uses of SPECT/CT. Eur J Nucl Med Mol
Imaging. 2010;37(10):1959–85.
41. Scharf S. SPECT/CT imaging in general orthopedic practice.
Semin Nucl Med. 2009;39(5):293–307.
42. Israel O, Keidar Z. PET/CT imaging in infectious conditions. Ann
N YAcad Sci. 2011;1228:150–66.
43. van der Bruggen W, Bleeker-Rovers CP, Boerman OC, Gotthardt
M, Oyen WJ. PET and SPECT in osteomyelitis and prosthetic
bone and joint infections: a systematic review. Semin Nucl Med.
2010;40(1):3–15.
44. Aliprandi A, Sconfienza LM, Randelli P, Bandirali M, Tritella S,
Di Leo G, et al. Magnetic resonance imaging of the knee after
medial unicompartmental arthroplasty. Eur J Radiol. 2011;80(3):
e416–21.
45. White LM, Kim JK, Mehta M, Merchant N, Schweitzer ME,
Morrison WB, et al. Complications of total hip arthroplasty: MR
imaging-initial experience. Radiology. 2000;215(1):254–62.
46. Hayter CL, Koff MF, Shah P, Koch KM, Miller TT, Potter HG.
MRI after arthroplasty: comparison ofMAVRIC and conventional
fast spin-echo techniques. AJR Am J Roentgenol. 2011;197(3):
W405–11.
47. He C, Lu Y, Jiang M, Feng J, Wang Y, Liu Z. Clinical value of
optimized magnetic resonance imaging for evaluation of patients
with painful hip arthroplasty. ChinMed J. 2014;127(22):3876–80.
48. Gille J, Ince A, González O, Katzer A, Loehr JF. Single-stage
revision of peri-prosthetic infection following total elbow replace-
ment. J Bone Joint Surg Br. 2006;88(10):1341–6.
49. Achermann Y, Stasch P, Preiss S, Lucke K, Vogt M.
Characteristics and treatment outcomes of 69 cases with early
prosthetic joint infections of the hip and knee. Infection.
2014;42(3):511–9.
50. Garcia RM, Hardy BT, Kraay MJ, Goldberg VM. Revision total
knee arthroplasty for aseptic and septic causes in patients with
rheumatoid arthritis. Clin Orthop Relat Res. 2010;468(1):82–9.
51. Magnuson JE, Brown ML, Hauser MF, Berquist TH, Fitzgerald
RH Jr, Klee GG. In-111-labeled leukocyte scintigraphy in
suspected orthopedic prosthesis infection: comparison with other
imaging modalities. Radiology. 1988;168(1):235–9.
52. Virolainen P, Lahteenmaki H, Hiltunen A, Sipola E, Meurman O,
Nelimarkka O. The reliability of diagnosis of infection during
revision arthroplasties. Scand J Surg. 2002;91(2):178–81.
53. Teller RE, ChristieMJ,MartinW, Nance EP, Haas DW. Sequential
indium labeled leukocyte and bone scans to diagnose prosthetic
joint infection. Clin Orthop Relat Res. 2000;373:241–7.
54. Bailey DL, Pichler BJ, Gückel B, et al. Combined PET/MRI: from
status quo to status go. Summary report of the fifth international
Eur J Nucl Med Mol Imaging
workshop on PET/MR imaging; February 15-19, 2016; Tübingen,
Germany. Mol Imaging Biol. 2016;18(5):637–50.
55. Omar M, Ettinger M, Reichling M, et al. Synovial C-reactive
protein as a marker for chronic periprosthetic infection in total
hip arthroplasty. Bone Joint J. 2015;97-B(2):173–6.
56. Alijanipour P, Bakhshi H, Parvizi J. Diagnosis of periprosthetic
joint infection: the threshold for serologic markers. Clin Orthop
Relat Res. 2013;471(10):3186–95.
57. Ghanem E, Ketonis C, Restrepo C, Joshi A, Barrack R, Parvizi J.
Periprosthetic infection: where do we stand with regard to Gram
stain? Acta Orthop. 2009;80(1):37–40.
58. Ali S, Christie A, Chapel A. The pattern of procalcitonin in pri-
mary total hip and knee arthroplasty and its implication in
periprosthetic infection. J Clin Med Res. 2009;1(2):90–4.
59. Berbari E, Mabry T, Tsaras G, et al. Inflammatory blood labora-
tory levels as markers of prosthetic joint infection: a systematic
review and meta-analysis. J Bone Joint Surg Am. 2010;92(11):
2102–9.
60. Bergin PF, Doppelt JD, Hamilton WG, et al. Detection of
periprosthetic infections with use of ribosomal RNA-based poly-
merase chain reaction. J Bone Joint Surg Am. 2010;92:654–63.
61. Zmistowsky B, Restrepo C, Huang R, Hozack WJ, Parvizi J.
Periprosthetic joint infection diagnosis: a complete understanding
of white blood cell count and differential. J Arthroplast.
2012;27(9):1589–93.
62. Cipriano CA, Brown NM, Michael AM, Moric M, Sporer SM,
Della Valle CJ. Serum and synovial fluid analysis for diagnosing
chronic periprosthetic infection in patients with inflammatory ar-
thritis. J Bone Joint Surg Am. 2012;94(7):594–600.
63. Della Valle GJ, Sporer SM, Jacobs JJ, Berger RA, Rosenberg AG,
PaproskyWG. Preoperative testing for sepsis before revision total
knee arthroplasty. J Arthroplast. 2007;22(6 suppl 2):90–3.
64. Elgeidi A, Elganainy AE, Abou Elkhier N, Rakha S. Interleukin-6
and other inflammatory markers in diagnosis of periprosthetic
joint infection. Int Orthop. 2014;38(12):2591–5.
65. Ettinger M, Calliess T, Kielstein JT, et al. Circulating biomarkers
for discrimination between aseptic joint failure, low-grade infec-
tion and high grade septic failure. Clin Infect Dis. 2015;61(3):
332–41.
66. Fink B, Makowiak C, Fuerst M, Berger I, Schäfer P, Frommelt L.
The value of synovial biopsy, joint aspiration and C-reactive pro-
tein in the diagnosis of late peri-prosthetic infection of total knee
replacements. J Bone Joint Surg Br. 2008;90(7):874–8.
67. Fink B, Gebhard A, Fuerst M, Berger I, Schäfer P. High diagnostic
value of synovial biopsy in periprosthetic joint infection of the hip.
Clin Orthop Relat Res. 2013;471(3):956–64.
68. Gallo J, Kolar M, Dendis M, et al. Culture and PCR analysis of
joint fluid in the diagnosis of prosthetic joint infection. New
Microbiol. 2008;31(1):97–104.
69. Bernard L, Lübbeke A, Stern R, et al. Value of preoperative in-
vestigations in diagnosing prosthetic joint infection: retrospective
cohort study and literature review. Scand J Infect Dis. 2004;36(6–
7):410–6.
70. Glehr M, Friesenbichler J, Hofmann G, et al. Novel biomarkers to
detect infection in revision hip and knee arthroplasties. Clin
Orthop Relat Res. 2013;471(8):2621–8.
71. Greidanus NV, Masri BA, Garbuz DS, et al. Use of erythrocyte
sedimentation rate and C-reactive protein level to diagnose infec-
tion before revision total knee arthroplasty: a prospective evalua-
tion. J Bone Joint Surg Am. 2007;89(7):1409–16.
72. Hoell S, Borgers L, Gosheger G, et al. Interleukin-6 in two-stage
revision arthroplasty: what is the threshold value to exclude per-
sistent infection before re-implantation? Bone Joint J. 2015;97-
B(1):71–5.
73. Gollwitzer H, Dombrowski Y, Prodinger PM, et al. Antimicrobial
peptides and proinflammatory cytokines in periprosthetic joint
infection. J Bone Joint Surg Am. 2013;95(7):644–51.
74. Ghanem E, Parvizi J, Burnett SJ, et al. Cell count and differential
of aspirated fluid in the diagnosis of infection at the site of total
knee arthroplasty. J Bone Joint Surg Am. 2008;90(8):1637–43.
75. Atkins BL, Athanasou N, Deeks JJ, et al. Prospective evaluation
of criteria for microbiological diagnosis of prosthetic-joint infec-
tion at revision arthroplasty. J Clin Microbiol. 1998;36(10):2932–
9.
76. Nilsdotter-Augustinsson A, Briheim G, Herder A, Ljunghusen O,
Wahlström O, Öhman L. Inflammatory response in 85 patients
with loosened hip prostheses: a prospective study comparing in-
flammatory markers in patients with aseptic and septic prosthetic
loosening. Acta Orthop. 2007;78(5):629–39.
77. Bottner F, Wegner A, Winkelmann W, Becker K, Erren M, Götze
C. Interleukin-6, procalcitonin and TNF-a: markers of peri-
prosthetic infection following total joint replacement. J Bone
Joint Surg Br. 2007;89(1):94–9.
78. Di Cesare PE, Chang E, Preston CF, Liu CJ. Serum interleukin-6
as a marker of periprosthetic infection following total hip and knee
arthroplasty. J Bone Joint Surg Am. 2005;87(9):1921–7.
79. Parvizi J, Jacovides C, Adeli B, Jung KA, Hozack WJ, Mark B.
Coventry award: synovial C-reactive protein: a prospective eval-
uation of a molecular marker for periprosthetic knee joint infec-
tion. Clin Orthop Relat Res. 2012;470(1):54–60.
80. Schinsky MF, Della Valle CJ, Sporer SM, Paprosky WG.
Perioperative testing for joint infection in patients undergoing
revision total hip arthroplasty. J Bone Joint Surg Am.
2008;90(9):1869–75.
81. Tetreault MW,Wetters NG,MoricM, Gross CE, Della Valle CJ. Is
synovial C-reactive protein a useful marker for periprosthetic joint
infection? Clin Orthop Relat Res. 2014;472(12):3997–4003.
82. Mason JG, Fehring TK, Odum SM, Griffin WL, Nussman DS.
The value of white blood cell counts before revision total knee
arthroplasty. J Arthroplast. 2003;18(8):1038–43.
83. Shanmugasundaram S, Ricciardi BF, Briggs TW, Sussmann PS
and Bostrom MP. Evaluation and management of periprosthetic
joint infection - an international, multicenter study. HSS J.
2014;10(1):36–44.
84. Murdoch DR, Roberts SA, Fowler VG Jr, et al. Infection of ortho-
pedic prostheses after Staphylococcus aureus bacteremia. Clin
Infect Dis. 2001;32(4):647e649.
85. Lyons CW, Berquist TH, Lyons JC, Rand JA, Brown ML.
Evaluation of radiographic findings in painful hip arthroplasties.
Clin Orthop Relat Res. 1985;195:239–51.
86. Tigges S, Stiles RG, Roberson JR. Appearance of septic hip pros-
theses on plain radiographs. AJR Am J Roentgenol. 1994;163(2):
377–80.
87. Math KR, Zaidi SF, Petchprapa C, Harwin SF. Imaging of total
knee arthroplasty. Semin Musculoskelet Radiol. 2006;10(1):47–
63 Review.
88. Van Holsbeeck MT, Eyler WR, Sherman LS, Lombardi TJ,
Mezger E, Verner JJ, et al. Detection of infection in loosened
hip prostheses: efficacy of sonography. AJR Am J Roentgenol.
1994;163:381–4.
89. Weybright PN, Jacobson JA, Murry KH, Lin J, Fessell DP,
Jamadar DA, et al. Limited effectiveness of sonography in reveal-
ing hip joint effusion: preliminary results in 21 adult patients with
native and postoperative hips. AJR Am J Roentgenol. 2003;181:
215–8.
90. Eisler T, Svensson O, Engström CF, Reinholt FP, Lundberg C,
Wejkner B, et al. Ultrasound for diagnosis of infection in revision
total hip arthroplasty. J Arthroplast. 2001;16(8):1010–7.
91. Battaglia M, Vannini F, Guaraldi F, Rossi G, Biondi F, Sudanese
A. Validity of preoperative ultrasound-guided aspiration in the
Eur J Nucl Med Mol Imaging
revision of hip prosthesis. Ultrasound Med Biol. 2011;37(12):
1977–83.
92. Tomas X, Bori G, Garcia S, Garcia-Diez AI, Pomes J, Soriano A,
et al. Accuracy of CT-guided joint aspiration in patients with
suspected infection status post-total hip arthroplasty. Skelet
Radiol. 2011;40(1):57–64.
93. Trampuz A, Piper KE, Hanssen AD, et al. Sonication of explanted
prosthetic components in bags for diagnosis of prosthetic joint
infection is associated with risk of contamination. J Clin
Microbiol. 2006;44(2):628–31.
94. Vasoo S, Cunningham SA, Greenwood-Quaintance KE, et al.
Evaluation of the film array blood culture ID panel on biofilms
dislodged from explanted arthroplasties for prosthetic joint infec-
tion diagnosis. J Clin Microbiol. 2015;53(8):2790–2.
95. Hindle P, Davidson E, Biant LC. Septic arthritis of the knee: the
use and effect of antibiotics prior to diagnostic aspiration. Ann R
Coll Surg Engl. 2012;94(5):351–5.
96. Cazanave C, Greenwood-Quaintance KE, Hanssen AD, et al.
Rapid molecular microbiologic diagnosis of prosthetic joint infec-
tion. J Clin Microbiol. 2013;51(7):2280–7.
97. Esteban J, Gomez-Barrena E, Cordero J, Martín-de-Hijas NZ,
Kinnari TJ, Fernandez-Roblas R. Evaluation of quantitative anal-
ysis of cultures from sonicated retrieved orthopedic implants in
diagnosis of orthopedic infection. J Clin Microbiol. 2008;46(2):
488–92.
98. Cheung A, Lachiewicz PF, Renner JB. The role of aspiration and
contrast-enhanced arthrography in evaluating the uncemented hip
arthroplasty. AJR Am J Roentgenol. 1997;168(5):1305–9.
99. Howard CB, Einhorn M, Dagan R, Yagupski P, Porat S. Fine-
needle bone biopsy to diagnose osteomyelitis. J Bone Joint Surg
Br. 1994;76(2):311–4.
100. Bonhoeffer J, Haeberle B, Schaad UB, Heininger U. Diagnosis of
acute haematogenous osteomyelitis and septic arthritis, 20 years
experience at the University Children’s Hospital Basel. SwissMed
Wkly. 2001;131(39–40):575–81.
101. Barrack RL, Harris WH. The value of aspiration of the hip joint
before revision total hip arthroplasty. J Bone Joint Surg Am.
1993;75(1):66–76.
102. Portillo ME, Salvadó M, Sorli L, et al. Multiplex PCR of sonica-
tion fluid accurately differentiates between prosthetic joint infec-
tion and aseptic failure. J Inf Secur. 2012;65(6):541–8.
103. Janz V, Wassilew GI, Kribus M, Trampuz A, Perka C. Improved
identification of polymicrobial infection in total knee arthroplasty
through sonicate fluid cultures. Arch Orthop Trauma Surg.
2015;135(10):1453–7.
104. Minassian AM, Newham R, Kalimeris E, Bejon P, Atkins BL,
Bowler ICJW. Use of an automated blood culture system (BD
BACTEC) for the diagnosis of prosthetic joint infections: easy
and fast. BMC Infect Dis. 2014;14:233.
105. Frangiamore SJ, Gajewski ND, Saleh A, Farias-Kovac M,
Barsoum WK, Higuera CA. Alfa-defensin accuracy to diagnose
periprosthetic joint infection - best available test? J Arthroplast.
2016;31(2):456–60.
106. Frangiamore SJ, Saleh A, Grosso MJ, et al. α-Defensin as a pre-
dictor of periprosthetic shoulder infection. J Shoulder Elb Surg.
2015;24(7):1021–7.
107. Cipriano C, Maiti A, Hale G, Jiranek W. The host response: toll-
like receptor expression in periprosthetic tissues as a biomarker for
deep joint infection. J Bone Joint Surg Am. 2014;96(20):1692–8.
108. Liu JZ, Saleh A, Klika AK, Barsoum WK, Higuera CA. Serum
inflammatory markers for periprosthetic knee infection in obese
versus non-obese patients. J Arthroplast. 2014;29(10):1880–3.
109. Bingham J, Clarke H, Spangehl M, Schwartz A, Beauchamp C,
Goldberg B. The alpha defensin-1 biomarker assay can be used to
evaluate the potentially infected total joint arthroplasty. Clin
Orthop Relat Res. 2014;472(12):4006–9.
110. Lenski M, Scherer MA. Synovial IL-6 as inflammatory marker in
periprosthetic joint infections. J Arthroplast. 2014;29(6):1105–9.
111. Jacovides CL, Parvizi J, Adeli B, Jung KA. Molecular markers for
diagnosis of periprosthetic joint infection. J Arthroplast. 2011;26(6
suppl):99–103.
112. Deirmengian C, Kardos K, Kilmartin P, Cameron A, Schiller K,
Parvizi J. Combinedmeasurement of synovial fluid alpha-defensin
and C-reactive protein levels: highly accurate for diagnosing
periprosthetic joint infection. J Bone Joint Surg Am.
2014;96(17):1439–45.
113. Deirmengian C, Kardos K, Kilmartin P, Cameron A, Schiller K,
Parvizi J. Diagnosing periprosthetic joint infection: has the era of
the biomarker arrived? Clin Orthop Relat Res. 2014;472(11):
3254–62.
114. Ali F,Wilkinson JM, Cooper JR, et al. Accuracy of joint aspiration
for the preoperative diagnosis of infection in total hip arthroplasty.
J Arthroplast. 2006;21(2):221–6.
115. Achermann Y, Vogt M, Leunig M, Wüst J, Trampuz J. Improved
diagnosis of periprosthetic joint infection by multiplex PCR of
sonication fluid from removed implants. J Clin Microbiol.
2010;48(4):1208–14.
116. Wetters NG, Berend KR, Lombardi AV, Morris MJ, Tucker TL,
Della Valla CJ. Leukocyte esterase reagent strips for the rapid
diagnosis of periprosthetic joint infection. J Arthroplast.
2012;27(8 suppl):8–11.
117. Mikkelsen DB, Pedersen C, Højbjerg T, Schønheyder HC. Culture
of multiple peroperative biopsies and diagnosis of infected knee
arthroplasties. APMIS. 2006;114(6):449–52.
118. Esteban J, Alonso-Rodriguez N, del Prado G, et al. PCR-
hybridization after sonication improves diagnosis of implant-
related infection. Acta Orthop. 2012;83(3):299–304.
119. Gomez E, Cazanave C, Cunningham SA, et al. Prosthetic joint
infection diagnosis using broad-range PCR of biofilms dislodged
from knee and hip arthroplasty surfaces using sonication. J Clin
Microbiol. 2012;50(11):3501–8.
120. Tunney MM, Patrick S, Curran MD, et al. Detection of prosthetic
hip infection at revision arthroplasty by immunofluorescence mi-
croscopy and PCR amplification of the bacterial 16S rRNA gene. J
Clin Microbiol. 1999;37(10):3281–90.
121. Rak M, Barlic-Maganja D, Kavcic M, Trebse R, Cor A.
Comparison of molecular and culture method in diagnosis of
prosthetic joint infection. FEMS Microbiol Lett. 2013;343(1):
42–8.
122. Morawietz L, Tiddens O, Mueller M, et al. Twenty-three neutro-
phil granulocytes in 10 high-power fields is the best histopatho-
logical threshold to differentiate between aseptic and septic
endoprosthesis loosening. Histopathology. 2009;54(7):847–53.
123. Spangehl MJ,Masterson E, Masri BA, O’Connell JX, Duncan CP.
The role of intraoperative gram stain in the diagnosis of infections
during revision total hip arthroplasty. J Arthroplast. 1999;14(8):
952–6.
124. Barrack RL, Jennings RW, Wolfe MW, Bertot AJ. The Coventry
award. The value of preoperative aspiration before total knee re-
vision. Clin Orthop Relat Res. 1997;345:8–16.
125. Datz FL, Thorne DA. Effect of antibiotic therapy on the sensitivity
of indium-111-labeled leukocyte scans. J Nucl Med. 1986;27(12):
1849–53.
126. McCarthy K, Velchik MG, Alavi A, Mandell GA, Esterhai JL,
Goll S. Indium-111-labeled white blood cells in the detection of
osteomyelitis complicated by a pre-existing condition. J Nucl
Med. 1988;29(6):1015–21.
127. Kolindou A, Liu Y, Ozker K, Krasnow AZ, Isitman AT, Hellman
RS, et al. In-111 WBC imaging of osteomyelitis in patients with
underlying bone scan abnormalities. Clin Nucl Med. 1996;21(3):
183–91.
Eur J Nucl Med Mol Imaging
128. Van der Wall H, Lunz D, Stanton F, Bruce W. Prognostic value of
99m Tc leukocyte scintigraphy in diabetic pedal osteomyelitis.
Foot Ankle Int. 2001;22(9):720–4.
129. Vesco L, Boulahdour H, Hamissa S, Kretz S, Montazel JL,
Perlemuter L, et al. The value of combined radionuclide and mag-
netic resonance imaging in the diagnosis and conservative man-
agement of minimal or localized osteomyelitis of the foot in dia-
betic patients. Metabolism. 1999;48(7):922–7.
130. Newman LG, Waller J, Palestro CJ, Schwartz M, Klein MJ,
Hermann G, et al. Unsuspected osteomyelitis in diabetic foot ul-
cers. Diagnosis and monitoring by leukocyte scanning with indi-
um 111 oxyquinoline. JAMA. 1991;266(9):1246–51.
131. Chik KK,MageeMA, BruceWJ, Higgs RJ, ThomasMG, Allman
KC, et al. Tc-99m stannous colloid-labeled leukocyte scintigraphy
in the evaluation of the painful arthroplasty. Clin Nucl Med.
1996;21(11):838–43.
132. Schmidt KG, Rasmussen JW, Wedebye IM, Frederiksen PB.
Analysis of factors that may affect the speed of accumulation of
111In-labelled granulocytes at sites of inflammation. Nucl Med
Commun. 1988;9(2):97–103.
133. Kim DG, Lee JI, Lee DS, Lee MC, Choi KS, Han DH. 99mTc-
HMPAO labeled leukocyte SPECT in intracranial lesions. Surg
Neurol. 1995;44(4):338–45.
134. Kristinsson JK, Sigurdsson H, Sigfusson A, Gudmundsson S,
Agnarsson BA. Detection of orbital implant infection with tech-
netium 99m-labeled leukocytes. Ophthal Plast Reconstr Surg.
1997;13:256–8.
135. Ascher NL, Forstrom L, Simmons RL. Radiolabeled autologous
leukocyte scanning in abscess detection. World J Surg. 1980;4:
395–402.
136. Knochel JQ, Koehler PR, Lee TG, Welch DM, et al. Diagnosis of
abdominal abscesses with computed tomography, ultrasound, and
indium-111leukocyte scans. Radiology. 1980;137:425–32.
137. Laitinen R, Tahtinen J, Lantto T, Vorne M. Tc-99m labeled leuko-
cytes in imaging of patients with suspected acute abdominal in-
flammation. Clin Nucl Med. 1990;15:597–602.
138. Challa S, Lyons KP, Broekelschen P, Milne N. Relative sensitivity
of Tc-99mWBC versus in-111 WBC in a patient with Crohn dis-
ease and steroid use. Clin Nucl Med. 1997;22:700–3.
139. Chung CJ, Hicklin OA, Payan JM, Gordon L. Indium-111-labeled
leukocyte scan in detection of synthetic vascular graft infection:
the effect of antibiotic treatment. J Nucl Med. 1991;32:13–5.
140. Ramackers JM, Kotzki PO, Couret I, Messner-Pellenc P, Davy
JM, Rossi M. The use of technetium-99m hexamethylpropylene
amine oxime labelled granulocytes with single-photon emission
tomography imaging in the detection and follow-up of recurrence
of infective endocarditis complicating transvenous endocardial
pacemaker. Eur J Nucl Med. 1995;22:1351–4.
141. Cyteval C, Hamm V, Sarrabère MP, Lopez FM, Maury P, Taourel
P. Painful infection at the site of hip prosthesis: CT imaging.
Radiology. 2002;224(2):477–83.
142. Cahir JG, Toms AP, Marshall TJ, Wimhurst J, Nolan J. CT and
MRI of hip arthroplasty. Clin Radiol. 2007;62(12):1163–71 dis-
cussion 1172–1173.
143. Roth TD, Maertz NA, Parr JA, Buckwalter KA, Choplin RH. CT
of the hip prosthesis: appearance of components, fixation, and
complications. Radiographics. 2012;32(4):1089–107.
144. Wong MY, Beadsmoore C, Toms A, Smith T, Donell S. Does
99mTc-MDP bone scintigraphy add to the investigation of pa-
tients with symptomatic unicompartmental knee replacement?
Knee. 2012;19(5):592–6.
145. Yue B, Tang T. The use of nuclear imaging for the diagnosis of
periprosthetic infection after knee and hip arthroplasties. Nucl
Med Commun. 2015;36(4):305–11.
146. Love C, Marwin SE, Palestro CJ. Nuclear medicine and the in-
fected joint replacement. Semin Nucl Med. 2009;39(1):66–78.
147. Nagoya S, Kaya M, Sasaki M, Tateda K, Yamashita T. Diagnosis
of peri-prosthetic infection at the hip using triple-phase bone scin-
tigraphy. J Bone Joint Surg Br. 2008;90(2):140–4.
148. TemmermanOP, Raijmakers PG, DevilleWL, Berkhof J, Hooft L,
Heyligers IC. The use of plain radiography, subtraction
arthrography, nuclear arthrography, and bone scintigraphy in the
diagnosis of a loose acetabular component of a total hip prosthesis:
a systematic review. J Arthroplast. 2007;22(6):818–27.
149. Ikeuchi M, Okanoue Y, Izumi M, Fukuda G, Aso K, Sugimura N,
et al. Diagnostic value of triple-phase bone scintigraphy for the
diagnosis of infection around antibiotic-impregnated cement
spacers. Springerplus. 2013;2:401. https://doi.org/10.1186/2193-
1801-2-401.
150. Nagoya S, Kaya M, Sasaki M, Tateda K, Yamashita T. Diagnosis
of peri-prosthetic infection at the hip using triple-phase bone scin-
tigraphy. J Bone Joint Surg Br. 2008 Feb;90(2):140–4.
151. Volpe L, Indelli PF, Latella L, Poli P, Yakupoglu J, Marcucci M.
Periprosthetic joint infections: a clinical practice algorithm. Joints.
2015 Feb 13;2(4):169–74.
152. Trevail C, Ravindranath-Reddy P, Sulkin T, Bartlett G. An evalu-
ation of the role of nuclear medicine imaging in the diagnosis of
periprosthetic infections of the hip. Clin Radiol. 2016 Mar;71(3):
211–9.
153. Ouyang Z, Li H, Liu X, Zhai Z, Li X. Prosthesis infection: diag-
nosis after total joint arthroplasty with three-phase bone scintigra-
phy. Ann Nucl Med. 2014;28(10):994–1003.
154. Glaudemans AW, de Vries EF, Vermeulen LE, Slart RH, Dierckx
RA, Signore A. A large retrospective single-centre study to define
the best image acquisition protocols and interpretation criteria for
white blood cell scintigraphy with99mTc-HMPAO-labelled
leucocytes in musculoskeletal infections. Eur J Nucl Med Mol
Imaging. 2013;40(11):1760–9.
155. Lima AL, Oliveira PR, Carvalho VC, Saconi ES, Cabrita HB,
Rodrigues MB. Periprosthetic joint infections. Interdiscip
Perspect Infect Dis. 2013;2013:542796.
156. Temmerman OP, Raijmakers PG, Berkhof J, David EF, Pijpers R,
Molenaar MA, et al. Diagnostic accuracy and interobserver vari-
ability of plain radiography, subtraction arthrography, nuclear
arthrography, and bone scintigraphy in the assessment of aseptic
femoral component loosening. Arch Orthop Trauma Surg.
2006;126(5):316–23.
157. Signore A, Glaudemans AW, Galli F, Rouzet F. Imaging infection
and inflammation. Biomed Res Int. 2015;2015:615150.
158. Palestro CJ. Nuclear medicine and the failed joint replacement:
past, present, and future. World J Radiol. 2014;6(7):446–58.
159. Jutte P, Lazzeri E, Sconfienza LM, Cassar-Pullicino V, Trampuz
A, Petrosillo N, et al. Diagnostic flowcharts in osteomyelitis,
spondylodiscitis and prosthetic joint infection. Q J Nucl Med
Mol Imaging. 2014;58(1):2–19.
160. Jamar F, Buscombe J, Chiti A, Christian PE, Delbeke D, Donohoe
KJ, et al. EANM/SNMMI guideline for 18F-FDG use in inflam-
mation and infection. J Nucl Med. 2013;54(4):647–58.
161. Kim HO, Na SJ, Oh SJ, Jung BS, Lee SH, Chang JS, et al.
U s e f u l n e s s o f a d d i n g S P E C T / C T t o 9 9 m Tc -
hexamethylpropylene amine oxime (HMPAO)-labeled leukocyte
imaging for diagnosing prosthetic joint infections. J Comput
Assist Tomogr. 2014;38(2):313–9.
162. Erba PA, Glaudemans AW, Veltman NC, Sollini M, Pacilio M,
Galli F, et al. Image acquisition and interpretation criteria for
99mTc-HMPAO-labelled white blood cell scintigraphy: results
of a multicentre study. Eur J Nucl Med Mol Imaging.
2014;41(4):615–23.
163. Sousa R, Massada M, Pereira A, Fontes F, Amorim I, Oliveira A.
Diagnostic accuracy of combined 99mTc-sulesomab and 99mTc-
nanocolloid bone marrow imaging in detecting prosthetic joint
infection. Nucl Med Commun. 2011;32(9):834–9.
Eur J Nucl Med Mol Imaging
164. Jung KP, Park JS, Lee AY, Choi SJ, Lee SM, Bae SK. The clinical
usefulness of (99m)Tc HMPAO leukocyte/(99m)Tc phytate bone
marrow scintigraphy for diagnosis of prosthetic knee infection: a
preliminary study. Nucl Med Mol Imaging. 2012;46(4):247–53.
165. Simonsen L, Buhl A, Oersnes T, Duus B. White blood cell scin-
tigraphy for differentiation of infection and aseptic loosening: a
retrospective study of 76 painful hip prostheses. Acta Orthop.
2007;78(5):640–7.
166. Basu S, Kwee TC, Saboury B, Garino JP, Nelson CL, Zhuang H,
Parsons M, Chen W, Kumar R, Salavati A, Werner TJ, Alavi A.
FDG PET for diagnosing infection in hip and knee prostheses:
prospective study in 221 prostheses and subgroup comparison
with combined (111)In-labeled leukocyte/(99m)Tc-sulfur colloid
bone marrow imaging in 88 prostheses.
167. Vanquickenborne B, Maes A, Nuyts J, Van Acker F, Stuyck J,
Mulier M, et al. The value of (18)FDG-PET for the detection of
infected hip prosthesis. Eur J Nucl MedMol Imaging. 2003;30(5):
705–15.
168. Pill SG, Parvizi J, Tang PH, Garino JP, Nelson C, Zhuang H, et al.
Comparison of fluorodeoxyglucose positron emission tomogra-
phy and(111)indium-white blood cell imaging in the diagnosis of
periprosthetic infection of the hip. J Arthroplast. 2006;21(6 Suppl
2):91–7.
169. Richter WS, Ivancevic V, Meller J, Lang O, Le Guludec D,
Szilvazi I, et al. 99mTc-besilesomab (Scintimun) in peripheral
osteomyelitis: comparison with 99mTc-labelled white blood cells.
Eur J Nucl Med Mol Imaging. 2011;38(5):899–910.
170. Palestro CJ. Radionuclide imaging of osteomyelitis. Semin Nucl
Med. 2015;45(1):32–46.
171. Pakos EE, Trikalinos TA, Fotopoulos AD, Ioannidis JP. Prosthesis
infection: diagnosis after total joint arthroplasty with
antigranulocyte scintigraphy with 99mTc-labeled monoclonal
antibodies—a meta-analysis. Radiology. 2007;242(1):101–8.
172. Xing D, Ma X, Ma J, Wang J, Chen Y, Yang Y. Use of anti-
granulocyte scintigraphy with 99mTc-labeled monoclonal anti-
bodies for the diagnosis of periprosthetic infection in patients after
total joint arthroplasty: a diagnostic meta-analysis. PLoS One.
2013;8(7):e69857.
173. Filippi L, Schillaci O. Usefulness of hybrid SPECT/CT in 99mTc-
HMPAO-labeled leukocyte scintigraphy for bone and joint infec-
tions. J Nucl Med, 47. 2006;(12):1908–13.
174. Graute V, Feist M, Lehner S, Haug A, Müller PE, Bartenstein P,
et al. Detection of low-grade prosthetic joint infections using
99mTc-antigranulocyte SPECT/CT: initial clinical results. Eur J
Nucl Med Mol Imaging. 2010;37(9):1751–9.
175. Schillaci O. Hybrid imaging systems in the diagnosis of osteomy-
elitis and prosthetic joint infection. Q J Nucl Med Mol Imaging.
2009;53(1):95–104 Review.
176. Pelosi E, Baiocco C, PennoneM, Migliaretti G, Varetto T, Maiello
A, et al. 99mTc-HMPAO-leukocyte scintigraphy in patients with
symptomatic total hip or knee arthroplasty: improved diagnostic
accuracy by means of semiquantitative evaluation. J Nucl Med.
2004;45(3):438–44.
177. Papós M, Barát F, Nárai G, Dillmann J, Láng J, Csernay L.
Tc-99m HMPAO leukocyte and Tc-99m nanocolloid scin-
tigraphy in posttraumatic bone infection. Clin Nucl Med.
1998;23(7):423–8.
178. Van Acker F, Nuyts J, Maes A, Vanquickenborne B, Stuyck J,
Bellemans J, et al. FDG-PET, 99mtc-HMPAO white blood cell
SPETand bone scintigraphy in the evaluation of painful total knee
arthroplasties. Eur J Nucl Med. 2001;28(10):1496–504.
179. Mulamba L, Ferrant A, Leners N, de Nayer P, Rombouts JJ,
Vincent A. Indium-111 leucocyte scanning in the evaluation of
painful hip arthroplasty. Acta Orthop Scand. 1983;54(5):695–7.
180. Palestro CJ, Kim CK, Swyer AJ, Capozzi JD, Solomon RW,
Goldsmith SJ. Total-hip arthroplasty: periprosthetic indium-111-
labeled leukocyte activity and complementary technetium-99m-
sulfur colloid imaging in suspected infection. J Nucl Med.
1990;31(12):1950–5.
181. Palestro CJ, Love C, Tronco GG, Tomas MB, Rini JN. Combined
labeled leukocyte and technetium 99m sulfur colloid bonemarrow
imaging for diagnosing musculoskeletal infection. Radiographics.
2006;26(3):859–70 Review.
182. Palestro CJ, Swyer AJ, Kim CK, Goldsmith SJ. Infected
knee prosthesis: diagnosis with in-111 leukocyte, Tc-99m
sulfur colloid, and Tc-99m MDP imaging. Radiology.
1991;179(3):645–8.
183. El Espera I, Blondet C,Moullart V, Saïdi L, Havet E,Mertl P, et al.
The usefulness of 99mTc sulfur colloid bone marrow scintigraphy
combined with 111In leucocyte scintigraphy in prosthetic joint
infection. Nucl Med Commun. 2004;25(2):171–5.
184. Joseph TN, Mujtaba M, Chen AL, Maurer SL, Zuckerman JD,
Maldjian C, et al. Efficacy of combined technetium-99m sulfur
colloid/indium-111 leukocyte scans to detect infected total hip
and knee arthroplasties. J Arthroplast. 2001;16(6):753–8.
185. Talbot BS, Weinberg EP. MR imaging with metal-suppression
sequences for evaluation of total joint arthroplasty.
Radiographics. 2016;36(1):209–25.
186. Sneag DB, Bogner EA, Potter HG. Magnetic resonance imaging
evaluation of the painful total knee arthroplasty. Semin
Musculoskelet Radiol. 2015;19(1):40–8.
187. Aliprandi A, Sconfienza LM, Randelli F, Bandirali M, Di Leo G,
Sardanelli F. Magnetic resonance imaging of painful total hip re-
placement: detection and characterisation of periprosthetic fluid
collection and interobserver reproducibility. Radiol Med.
2012;117(1):85–95.
Eur J Nucl Med Mol Imaging
